Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations

Clin Lung Cancer. 2020 Jul;21(4):e265-e269. doi: 10.1016/j.cllc.2020.02.016. Epub 2020 Feb 25.
No abstract available

Keywords: Immune checkpoint therapy; Immunotherapy; Lobectomy; Minimally invasive; Non–small-cell lung cancer.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Combined Modality Therapy
  • Female
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery*
  • Middle Aged
  • Minimally Invasive Surgical Procedures / methods*
  • Pneumonectomy / methods*
  • Prognosis

Substances

  • Immune Checkpoint Inhibitors